Humacyte, Inc. - *W EXP 08/27/202 (HUMAW)

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / *W EXP 08/27/202
Total 13F shares
429,978
Share change
+537
Total reported value
$113,278
Price per share
$0.27
Number of holders
6
Value change
-$2,216
Number of buys
2
Number of sells
3

Institutional Holders of Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) as of Q3 2025

As of 30 Sep 2025, Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 429,978 shares. The largest 6 holders included LPL Financial LLC, JANE STREET GROUP, LLC, WOLVERINE ASSET MANAGEMENT LLC, Sio Capital Management, LLC, TORONTO DOMINION BANK, and UBS Group AG. This page lists 6 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.